Myeloproliferative diseases

MYELOPROF

No definition available.

Endpoint definition

FinnGen phenotype data

321302 individuals

diagram downward connector

Apply sex-specific rule None

321302

diagram downward connector

Check conditions None

321302

diagram downward connector

Filter registries None

0

diagram downward connector

Check pre-conditions, main-only, mode, ICD version None

0

diagram downward connector

Check minimum number of events None

0

diagram downward connector
MYELOPROF

Extra metadata

First used in FinnGen datafreeze DF2, additional

Summary Statistics

Key figures

All Female Male
Number of individuals 1494 782 712
Unadjusted prevalence (%) 0.48 0.45 0.53
Mean age at first event (years) 60.65 59.77 61.61

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 0.04 3.60 [2.47, 5.24] 2.8e-11 257
15 years 0.01 1.79 [1.24, 2.58] 2.0e-3 112
5 years 0.00 3.24 [2.31, 4.54] 9.6e-12 75
1 year - - - -

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

Index endpoint: MYELOPROF – Myeloproliferative diseases
GWS hits: 7

Survival analyses between endpoints

Plot

before Myeloproliferative diseases
after Myeloproliferative diseases

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Myeloproliferative diseases